These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 33498772)

  • 1. Toward a Better Testing Paradigm for Developmental Neurotoxicity: OECD Efforts and Regulatory Considerations.
    Sachana M; Shafer TJ; Terron A
    Biology (Basel); 2021 Jan; 10(2):. PubMed ID: 33498772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential of mechanistic information organised within the AOP framework to increase regulatory uptake of the developmental neurotoxicity (DNT) in vitro battery of assays.
    Sachana M; Willett C; Pistollato F; Bal-Price A
    Reprod Toxicol; 2021 Aug; 103():159-170. PubMed ID: 34147625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Regulatory and Scientific Effort for Improved Developmental Neurotoxicity Testing.
    Sachana M; Bal-Price A; Crofton KM; Bennekou SH; Shafer TJ; Behl M; Terron A
    Toxicol Sci; 2019 Jan; 167(1):45-57. PubMed ID: 30476307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revolutionizing developmental neurotoxicity testing - a journey from animal models to advanced in vitro systems.
    Smirnova L; Hogberg HT; Leist M; Hartung T
    ALTEX; 2024; 41(2):152-178. PubMed ID: 38579692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scientific Validation of Human Neurosphere Assays for Developmental Neurotoxicity Evaluation.
    Koch K; Bartmann K; Hartmann J; Kapr J; Klose J; Kuchovská E; Pahl M; Schlüppmann K; Zühr E; Fritsche E
    Front Toxicol; 2022; 4():816370. PubMed ID: 35295221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probabilistic modelling of developmental neurotoxicity based on a simplified adverse outcome pathway network.
    Spînu N; Cronin MTD; Lao J; Bal-Price A; Campia I; Enoch SJ; Madden JC; Mora Lagares L; Novič M; Pamies D; Scholz S; Villeneuve DL; Worth AP
    Comput Toxicol; 2022 Feb; 21():100206. PubMed ID: 35211661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies to improve the regulatory assessment of developmental neurotoxicity (DNT) using in vitro methods.
    Bal-Price A; Pistollato F; Sachana M; Bopp SK; Munn S; Worth A
    Toxicol Appl Pharmacol; 2018 Sep; 354():7-18. PubMed ID: 29476865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A perspective on In vitro developmental neurotoxicity test assay results: An expert panel review.
    Juberg DR; Fox DA; Forcelli PA; Kacew S; Lipscomb JC; Saghir SA; Sherwin CM; Koenig CM; Hays SM; Kirman CR
    Regul Toxicol Pharmacol; 2023 Sep; 143():105444. PubMed ID: 37442267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances and current challenges of new approach methodologies in developmental and adult neurotoxicity testing.
    Serafini MM; Sepehri S; Midali M; Stinckens M; Biesiekierska M; Wolniakowska A; Gatzios A; Rundén-Pran E; Reszka E; Marinovich M; Vanhaecke T; Roszak J; Viviani B; SenGupta T
    Arch Toxicol; 2024 May; 98(5):1271-1295. PubMed ID: 38480536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A high-level overview of the OECD AOP Development Programme.
    Chauhan V; Hamada N; Wilkins R; Garnier-Laplace J; Laurier D; Beaton D; Tollefsen KE
    Int J Radiat Biol; 2022; 98(12):1704-1713. PubMed ID: 35938955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective performance assessment of the developmental neurotoxicity study in support of OECD test guideline 426.
    Makris SL; Raffaele K; Allen S; Bowers WJ; Hass U; Alleva E; Calamandrei G; Sheets L; Amcoff P; Delrue N; Crofton KM
    Environ Health Perspect; 2009 Jan; 117(1):17-25. PubMed ID: 19165382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of neurotoxicology (NT)/developmental neurotoxicology (DNT) adverse outcome pathways and key event linkages with in vitro DNT screening assays.
    Pitzer EM; Shafer TJ; Herr DW
    Neurotoxicology; 2023 Dec; 99():184-194. PubMed ID: 37866692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International STakeholder NETwork (ISTNET): creating a developmental neurotoxicity (DNT) testing road map for regulatory purposes.
    Bal-Price A; Crofton KM; Leist M; Allen S; Arand M; Buetler T; Delrue N; FitzGerald RE; Hartung T; Heinonen T; Hogberg H; Bennekou SH; Lichtensteiger W; Oggier D; Paparella M; Axelstad M; Piersma A; Rached E; Schilter B; Schmuck G; Stoppini L; Tongiorgi E; Tiramani M; Monnet-Tschudi F; Wilks MF; Ylikomi T; Fritsche E
    Arch Toxicol; 2015 Feb; 89(2):269-87. PubMed ID: 25618548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated Approaches to Testing and Assessment: OECD Activities on the Development and Use of Adverse Outcome Pathways and Case Studies.
    Sakuratani Y; Horie M; Leinala E
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123 Suppl 5():20-28. PubMed ID: 29316278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zebrafish and nematodes as whole organism models to measure developmental neurotoxicity.
    Hughes S; Hessel EVS
    Crit Rev Toxicol; 2024 May; 54(5):330-343. PubMed ID: 38832580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An analysis of the limitations and uncertainties of in vivo developmental neurotoxicity testing and assessment to identify the potential for alternative approaches.
    Paparella M; Bennekou SH; Bal-Price A
    Reprod Toxicol; 2020 Sep; 96():327-336. PubMed ID: 32781019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoids and developmental neurotoxicity: Utilizing toxicogenomics to enhance adverse outcome pathways and testing strategies.
    Chen H; Chidboy MA; Robinson JF
    Reprod Toxicol; 2020 Sep; 96():102-113. PubMed ID: 32544423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An industry perspective: A streamlined screening strategy using alternative models for chemical assessment of developmental neurotoxicity.
    Li J; Settivari R; LeBaron MJ; Marty MS
    Neurotoxicology; 2019 Jul; 73():17-30. PubMed ID: 30786249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A developmental neurotoxicity adverse outcome pathway (DNT-AOP) with voltage gate sodium channel (VGSC) inhibition as a molecular initiating event (MiE).
    ; Crofton KM; Paparella M; Price A; Mangas I; Martino L; Terron A; Hernández-Jerez A
    EFSA J; 2024 Aug; 22(8):e8954. PubMed ID: 39109086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An expert-driven literature review of "negative" chemicals for developmental neurotoxicity (DNT) in vitro assay evaluation.
    Martin MM; Baker NC; Boyes WK; Carstens KE; Culbreth ME; Gilbert ME; Harrill JA; Nyffeler J; Padilla S; Friedman KP; Shafer TJ
    Neurotoxicol Teratol; 2022; 93():107117. PubMed ID: 35908584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.